SecBot SecBot
144 ·Filed Aug 12, 2026

SEPN

Septerna, Inc.
BEARISH
Impact 5/10
Horizondays Processed3mo ago SEC0001178937-26-000042
Form 144, notice of proposed sale of securities
Actionable Insight ▼ Bearish

Traders should monitor for the actual execution of this sale, as a large affiliate sale by a key pre-IPO investor could signal reduced conviction or portfolio rebalancing. Watch for any subsequent Form 4 filings confirming the transaction and any impact on the stock price, especially given the stock's recent volatility and the historical underperformance of high-score calls on SEPN.

DirectionBearish
Confidencemedium
Horizondays

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$45.14
T+0 close · Aug 12, 2026 · via day close
Latest settled
+8.22%
T+60 · $48.85
Vs SPY
+13.69%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 13 $45.14entry
  2. T+1 · 3mo ago −1.42%α −1.22% · $44.50
  3. T+5 · 3mo ago −9.64%α −7.67% · $40.79
  4. T+20 · 2mo ago −14.69%α −12.94% · $38.51
  5. T+60 · 11d ago +8.22%α +13.69% · $48.85

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

RA Capital Healthcare Fund LP, a major pre-IPO investor in Septerna, filed a Form 144 on August 12, 2026, signaling intent to sell 746,500 shares of common stock, valued at approximately $35.97 million. This represents a significant proposed sale by a large insider affiliate, potentially indicating a desire to monetize a portion of its holdings post-IPO lock-up expiration, though the filing is an advance notice of intent, not a completed sale.

Key Facts

  • RA Capital Healthcare Fund LP filed Form 144 to sell 746,500 shares of Septerna common stock.
  • The proposed sale value is approximately $35.97 million based on an estimated market price of $48.20 per share.
  • The shares were acquired on October 25, 2024, through the IPO settlement, making this a sale of restricted securities by an affiliate.
  • The filing date is August 12, 2026, and the sale is intended to be executed through BTIG LLC.
  • RA Capital is a significant pre-IPO investor, and this proposed sale represents a substantial portion of its holdings.

Financial Impact

Proposed sale of 746,500 shares valued at ~$35.97 million, representing approximately 1.6% of Septerna's $2.2B market cap.

dilutioninsider selling

Risk Factors

  • The sale may not be executed; Form 144 is an intent to sell, not a guarantee.
  • Large insider selling by a major investor could pressure the stock price if the market interprets it as a lack of confidence.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001178937-26-000042
Document: 0001178937-26-000042-index.html0001178937-26-000042
Document: 0001178937-26-000042.txt0001178937-26-000042

US Market Status

Market Closed · Opens Wed (11h 56m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 12, 2026